Skip to content
2000
Volume 13, Issue 4
  • ISSN: 1567-2050
  • E-ISSN: 1875-5828

Abstract

Traditionally the brain has been viewed as being an immune-privileged organ. However, endogenous stimuli such as the presence of misfolded or aggregated proteins, as well as systemic inflammatory events may lead to the activation of microglial cells, the brain´s innate immune system, and, subsequently, to neuroinflammation. Alzheimer's disease, the leading cause of dementia, is characterized by amyloid beta deposition and tau hyperphosphorylation. Neuroinflammation in Alzheimer's disease has been identified as major contributor to disease pathogenesis. Once activated, microglia release several pro and anti-inflammatory mediators of which several affect the function and structure of the brain. Modulation of this microglial activation in Alzheimer's disease might open new therapeutic avenues.

Loading

Article metrics loading...

/content/journals/car/10.2174/1567205013666151116125012
2016-04-01
2025-07-11
Loading full text...

Full text loading...

/content/journals/car/10.2174/1567205013666151116125012
Loading

  • Article Type:
    Research Article
Keyword(s): Alzheimer's; amyloid-β; cytokines; microglia; neurodegeneration; neuroinflammation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test